AI-designed bird flu vaccine protects animals in Cambridge study
Researchers at the University of Cambridge published a study in 2026 showing an artificial intelligence vaccine fully protected mice and ferrets against multiple bird flu strains.
New vaccine outperforms stockpiled shots
Professor Jonathan Heeney led the research team that developed this experimental treatment. The study published in Cell Reports Medicine found all animals receiving the AI vaccine survived exposure to mixed virus variants. In contrast, only about half of the animals vaccinated with conventional shots survived the same challenge. Independent laboratories in Canada and Italy validated these effectiveness results against viruses collected from different global sources.
Scientists target shared viral features
To create unique antigens, the group examined genetic data gathered from bird flu strains found via global monitoring efforts. Instead of concentrating on one specific variant, these super-antigens merge common traits present in many different strains. Co-researcher Sneha Vishwanath explained that these designed antigens do not naturally exist in any known virus. The approach aims to interfere with several mechanisms involved in viral replication to stop different strains from spreading.
Human trials remain necessary next
Although animal studies showed promise, the vaccine remains untested in human clinical trials. Researchers state that trials on mice and ferrets do not prove human safety for this vaccine. Human trials conducted in 2026 reportedly showed that a coronavirus vaccine created with an identical AI methodology was safe. In 2026, reports emerged of bird flu viruses appearing in Australia and New Zealand, heightening worries regarding worldwide dissemination.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.